Evidence map›Paper›PMID 42080267›Full record

ArticleNucleic acids research2026

AlphaFold3-guided tracrRNA redesign yields small monomeric Cas12f RNPs.

Lulu Pan, Rui Sang, Ruier Xue, Yongcheng Ma, Ewa Goldys, Fei Deng

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lulu PanSchool of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney 2052, Australia.
Rui SangSchool of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney 2052, Australia.
Ruier XueSchool of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney 2052, Australia.
Yongcheng MaCentral China Fuwai Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China.
Ewa GoldysSchool of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney 2052, Australia.
Fei DengSchool of Biomedical Engineering, Faculty of Engineering, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-5606-0278

Funding

ARC DP240103024Cancer Institute NSW 2024/ECF1573Henan Province High-level Talent International Exchange ProjectHenan Provincial Natural Science Foundation 252300423880NHMRC 2030464UNSW SHARP
6 · The paper itself

Abstract

Although Cas12f (Cas14) is among the smallest Class 2 CRISPR (clustered regularly interspaced short palindromic repeats) effectors, it assembles into dimeric ribonucleoprotein (RNP) complexes with guide RNA, substantially increasing its functional size and limiting its suitability for gene editing and biosensing applications. To overcome this limitation, we systematically investigate the structural and functional roles of Cas12f dimerization using a combination of computational modeling and experimental validation. Structural analysis using Protein Data Bank data and AlphaFold-3 predictions revealed that the 5'-end sequence of tracrRNA is essential for dimer formation but dispensable for substrate cleavage. Based on this, we designed a truncated tracrRNA by removing 70 nucleotides from its 5'-end. This shortened tracrRNA successfully loaded into Cas12f to form a one guide RNA-one Cas12f monomer RNP. This functionally monomeric RNP demonstrated substantially enhanced trans-cleavage activity: 4.5-fold for ssDNA, 3.5-fold for dsDNA, and 2.5-fold for RNA, resulting in markedly improved detection sensitivity: 10-fold for ssDNA and dsDNA, and 4-fold for RNA. In addition, the functionally monomeric RNP exhibits cis-cleavage activity and gene editing efficiency comparable to that of the dimeric RNP, thereby restoring the advantage of Cas12f as a compact enzyme for in vivo gene editing. These results highlight that the functionally monomeric Cas12f RNP combines enhanced biosensing performance with retention of its uniquely compact size, benefiting gene editing applications.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsCRISPR-Cas SystemsDNADNA, Single-StrandedModels, MolecularProtein MultimerizationRNABacterial ProteinsCRISPR-Associated ProteinsDNADNA, Single-StrandedRibonucleoproteinsRNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID42080267
PMCPMC13137049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.